It has been a good period for long-suffering investors in German conglomerate Bayer (DE:BAYN).
The share price has risen by close to 25 per cent over the past month, as investors sensed that an end to the longstanding litigation over weedkiller Roundup may finally be in sight.
A court victory at the end of June means the class settlement already agreed will probably be the end of the Roundup payouts, with a further August hearing set to confirm the $7.25bn (£5.4bn) payout plan, which would be handed out over a period of up to 21 years.